INTRODUCTION
Aquaculture represents the fastest growing animal husbandry in many countries world-wide. The demand for fi sh and shellfi sh continues to rise. Losses incurred by fi sh farmers are related to disease, fl oods, oxygen depletions, predation, chemical poisoning, the , and miscellaneous causes. Disease is by far the most signifi cant factor (Meyer, 1991) . Many of the pathogens that cause disease in fi sh and shellfi sh are facultative forms that are ubiquitous in aquatic systems. In nature, a high percentage of apparently normal and healthy animals harbour potential pathogens without evidence of clinical signs or overt disease (Wedemeyer, 1970) . The development of disease in aquaculture systems usually occurs as the end result of a disruption of normal environment in which the animals are being reared. Unfavourable conditions, such as crowding, temperature fl uctuations, inadequate dissolved oxygen, excessive handling, physical abuse, inadequate diets, or toxic substances may stress the animals (Wedemeyer et al., 1976) . Stress is considered to be an important predisposing factor in most bacterial diseases of fi sh and shellfi sh and is o en followed by clinical disease. In many cases, prompt reduction of stressful conditions may lead to self-cure without the need to resort to chemotherapy (Meyer, 1991) .
Intensive fi sh production world-wide has increased the risk of infectious diseases. However, before any infection can be established, pathogens must penetrate the primary barrier. In fi sh, the three major routes of infection are the skin, gills, and gastrointestinal (GI) tract. The GI tract is essentially a muscular tube lined by a mucous membrane of columnar epithelial cells that exhibit a regional variation in structure and function (Ringø et al., 2010a) .
Wild fi sh are common hosts to a wide array of parasitic forms, but they seldom aff ect the survival of populations. In culture situations, conditions are favourable only to relatively few parasite species, but their impact is far greater than it would be in natural waters. Fry, fi ngerling, or larval stages are exceedingly vulnerable to adverse eff ects of parasitism. In addition to mortality, parasites may cause cessation of feeding, reduced growth, susceptibility to bacterial or fungal pathogens, and physical deformities. In salmonid culture, serious problems can be caused mainly by Ichthyophthirius, Ichthyobodo, Chilodonella, Trichodina, monogenea, and sporozoans (Meyer, 1991) . Moreover, other parasite species can cause serious problems, when their full developmental cycle takes place in a fi sh breeding (Palíková et al., 2014) .
Viral diseases cause serious problems in every aspect of aquaculture. If precautions are not taken to prevent the introduction of a viral agent, severe economic losses can occur. Infectious haematopoietic necrosis, infectious pancreatic necrosis and viral haemorrhagic septicaemia are the major viral diseases of trout and salmon (Wolf, 1988) in our conditions. Infectious haematopoietic necrosis and viral haemorrhagic septicaemia are dangerous diseases subjected to regular monitoring according law.
Bacterial pathogens overall probably cause more disease problems than all other causes combined. In virtually every type of aquaculture, bacterial diseases rank number one among etiological agents. Septicaemias and cutaneous lesions are among the manifestations of bacterial infections (Meyer, 1991) . The major bacterial diseases of trout and salmon in our conditions include furunculosis, enteric redmouth disease, and fl avobacterial diseases.
Most infectious bacterial diseases in commercial fi sh species continue to be controlled by treatment with chemotherapeutic agents. Chemical therapies are widely used in aquaculture although they represent a potential environmental hazard and could also have negative eff ects on the quality of the fi nal product (Bagni et al., 2000) . Moreover, when antibiotics are used in aquaculture, the drugs typically remain in the open environment and may fl ow out of production facilities into open waterways or sewage systems, where they may also interact with other environmental contaminants (Benbrook, 2002) . The most important problem of antibiotic treatment is the increase in resistant bacteria, presence of their residues in aquaculture products and the resulting threat to human health. Smidth et al. (2000) found that many bacteria in and around four trout farms were resistant to most antibiotic agents presently available for use in Danish aquaculture.
Chemotherapy should be considered as an emergency or last resort measure. Although chemicals may reduce the incidence of pathogens or control the abundance of facultative organisms, they may also have negative eff ects on the fl ora of biological fi lters (Meyer, 1991) .
Unfortunately, aquaculture is driven by commercial forces, and stocking densities and rearing conditions are adjusted to maximize returns within the limits of acceptable risk. Within this scheme antibacterial agents are used widely (Inglis, 2000) .
In any animal husbandry, measures to prevent the introduction or onset of disease are always the most eff ective, cost-effi cient, and long-lasting. Successful preventive measures in aquaculture center on 1) preventing the introduction of pathogens, 2) maintenance of good water quality, 3) avoidance or reduction of environmental stressors, 4) adequate nutrition, 5) isolation of cultured animals from feral stocks, and 6) immunization (Meyer, 1991) .
Also many substances improving the health status of fi sh sich as immunostimulants, probiotics, prebiotics, symbiotics and so on, are used in fi sh breeding.
VACCINATION
Vaccination is an important disease management strategy used to maintain good health in humans and animals worldwide as an ideal method of preventing infectious diseases. Vaccines developed for aquaculture have reduced the use of antibiotics in fi sh production. Original fi sh vaccines were bacterins (formalin-killed bacteria) delivered through immersion or injection that induced humoral (antibody) immunity. Next generation vaccines relied on multiple killed antigens delivered with an adjuvant to enhance vaccine eff ectiveness. Following work showed the use of various strategies to develop modifi ed live vaccines for use in fi sh. A modifi ed live vaccine is a live pathogen that has been rendered non-pathogenic or avirulent by physical, chemical, or genetic engineering methods. Modifi ed live vaccines are advantageous in that they can be easily delivered (i.e., by immersion to young fi sh) and stimulate both humoral and cellular immunity of long duration. Disadvantages include issues with modifi ed live vaccine safety to the host and environment (Shoemaker and Klesius, 2009) . Another possibility of disease control is the development of DNA vaccines (Sommerset et al., 2005) .
There are many commercial vaccines available on the market. Most of these vaccines are for the control of bacterial diseases in aquacultural breeding of salmonid fi sh, especially in the breeding of Atlantic salmon and rainbow trout. Vaccination in the conditions of the Czech Republic is on a low level. Vaccination of salmonid fi sh against listed exotic and non exotic viral diseases is not possible according to legislative rules. Vaccines against parasitic diseases are not available. Vaccination is possible only against bacterial diseases. The situation is complicated by the requirement that the vaccines must be registered in the Czech Republic. The following commercial vaccines are registered in the Czech Republic: AquaVac ERM oral (oral emulsion for rainbow trout against yersiniosis -ERM), AquaVac ERM (concentrate for soaking suspension for rainbow trout against yersiniosis), AquaVac FNM PLUS (inject emulsion for fi sh against furunculosis), and AquaVac relera (concentrate for emulsion for bath or for emulsion for injection against yersiniosis -ERM). It follows from this listing that there is no immersion vaccine available against furunculosis. This situation can be dealt by preparing a specifi c vaccine with formalinkilled bacteria strains isolated from fi sh on the given farm.
Although mineral oil-adjuvanted injection vaccines are by far the most effi cient in protection against diseases, the use of these vaccines o en results in adverse side eff ects including extensive adhesions and pigmentation of the peritoneum (Utoloki et al., 2006) . Therefore, alternative ecofriendly treatments must be considered. Treatments that may have a less signifi cant environmental impact include the strategic use of immunestimulants, probiotics and prebiotics.
IMMUNOSTIMULANTS
Immunostimulants represent a modern and promising tool in aquaculture, enhancing the resistance of cultured fi sh to disease and stress. The objectives of immunostimulation in fi sh include not only promoting a greater and more eff ective immune response to infectious agents, but also overcoming the immunosuppressive eff ects of stress (Anderson, 1992) . Many groups of substances are known to have an immunostimulant eff ect in terrestrial animals, but few of them have been shown to be eff ective in fi sh. These include glucans and nutritional factors such as ascorbic acid and -tocopherol (Bagni, 2000) . Beta-glucans are the most commonly used term for a heterogeneous group of glucose polysaccharides consisting of a backbone of -(1.3)-linked -D-glucopyranosyl units with -(1.6)-linked side chains of varying length and distribution (Rodríguez et al., 2009 ). They are a major structural component of fungi cell walls and are also found in some bacteria, plants, algae, yeast, and mushrooms. One of the most common sources of -glucans is derived from the cell wall of baker's yeast Saccharidomyces cerevisiae (Das et al., 2009) . Currently, -1.3/1.6 glucans from baker's yeast Saccharidomyces cerevisiae with high purity and activity are considered the most eff ective immunomodulators and are produced commercially e.g by Biorigin as MacroGard. Betaglucans bind to specifi c cell surface receptors of macrophages and neutrophilic granulocytes (Brown and Gordon, 2003) . Beta-glucans are capable of enhancing the innate immunity by increasing plasma lysozyme and complement and stimulate the phagocytic activity of macrophages in several cultured fi sh species (Yano et al., 1991; Chen and Ainsworth, 1992; Jorgensen et al., 1993; Galeotti, 1998; Jeney and Anderson, 1993) . Beta-glucans enhance fi sh resistance against bacterial and viral infections by means of eff ective stimulation of nonspecifi c cellular and humoral immune functions and have a proven protective eff ect against fi sh bacterial pathogens including A. salmonicida (Nikl et al., 1993) . In addition to individual administration, -glucans have also been used with bacterial vaccines as adjuvants (Figueras et al., 1998) or with lipopolysacharide as synergiens (Cook et al., 2001) so as to increase the immune response and to protect fi sh against pathogens. The use of -glucans in prospering, clinically healthy aquaculture is questionable, and does not have to result in a specifi c eff ect on the immune system response, nevertheless, their usefulness in a breeding endangered by stress stimuli, infectious diseases or adverse environmental factors is indisputable (Dobsikova et al., 2012) . Similarly, ascorbic acid can stimulate the natural immune response through macrophage and complement activities; dietary concentrations signifi cantly infl uence resistance to diseases (Waagboo, 1994; Dunier et al., 1995; Verlhac et al., 1996) . Dietary levels of -tocopherol are also relevant to immune responsiveness in farmed fi sh, since suboptimal levels may impair both humoral and cell-mediated immunity, in particular the phagocytic activity of macrophages (Blazer and Wolke, 1984) . It is worth considering that the immune response is o en diminished with a long-term use of immunostimulants which o en leads to the immune status reverting back to control levels or in extreme cases to immunosuppression (Sakai, 1999; Bricknell and Dalmo, 2005) .
PROBIOTICS
The defi nition of a probiotic diff ers greatly depending on the source. Recent defi nitions describe the probiotic as any microbial cell provided via the diet or rearing water that benefi ts the host fi sh, fi sh farmer or fi sh consumer, which is achieved, at least in part, by improving the microbial balance of the fi sh. In this context, direct benefi ts to the host such as immune-stimulation, improved disease resistance, reduced stress response, improved GI morphology etc., and benefi ts to the fi sh farmer or consumer such as improved fi sh appetite, growth performance, feed utilization, improvements of skeleton quality, fl esh quality and reduced malformations, are regarded (Merrifi eld et al., 2010) . The population of endogenous microbiota may depend on genetic, nutritional, and environmental factors. However, microorganisms present in the immediate environment of aquatic species have a much greater infl uence on the health status than is the case with terrestrial animals or humans. The gut microbiota of aquatic animals probably comprise indigenous microbiota together with artifi cially high levels of allochthonous bacteria maintained by their constant ingestion from the surrounding water (Ringø and Birkbeck, 1999) .
A wide range of microalgae (Tetraselmis), yeasts (Debaryomyces, Phaffi a and Saccharomyces) and Grampositive (Bacillus, Carnobacterium, Enterococcus, Lactobacillus, Lactococcus, Micrococcus, Streptococcus a Weissella) and Gram-negative bacteria (Aeromonas, Alteromonas, Photorhodobacterium, Pseudomonas a Vibrio) has been evaluated. Probiotics actively inhibit the colonization of potential pathogens in the digestive tract by antibiosis or by competition for nutrients and/or space, alteration of microbial metabolism, and/or by stimulation of the host's immunity. Probiotics may improve nutrition by the production of vitamins, detoxifi cation of compounds in the diet, and breakdown of indigestible components (Irianto and Austin, 2002a) . The bacteria do not permanently colonize the intestinal system of fi sh but need to be continuously introduced with the feed (Autin, 2010) . The potential of probiotic administrations to improve resistance against viral infections of fi sh is presently unknown. If probiotics can enhance the immune status, it is reasonable to speculate that this may reduce susceptibility to viral infections (Merrifi eld et al., 2010) . Probiotics, such as Lactobacillus rhamnosus, have been demonstrated to reduce rotavirus and poliovirus infections in humans (Marteau et al., 2001; De Vrese et al., 2005) . On the other hand, many studies have focused on probiotics improving resistance against bacterial diseases and reducing mortality of fi sh including salmonids, and reviews have been published of the use of probiotics in aquaculture and in salmonids (Balcázar et al., 2006; Merrifi eld et al., 2010) . Moreover, when the GI tract is involved as an infection route, mucosal adhesion is considered to be a critical early phase in all infections caused by pathogenic bacteria (Knudsen et al., 1999; Namba et al., 2007) . When the bacteria are able to colonize the intestinal mucus, they can cross the GI tract lining by transcellular or intracellular routes. Probiotic strains of Carnobacterium sp. have been demonstrated to augment immune responses in rainbow trout, upon challenge with fi sh pathogens A. salmonicida and Yersinia ruckeri, increasing phagocytic activity, respiratory burst as well as serum and gut mucosal lysozyme activity and the expression of IL-1 and TNF in head kidney leukocytes Austin, 2006a, 2006b) . Similarly, Panigrahi et al. (2007) describe augmentation of innate immunity using three freeze-dried probionts (Lactococcus rhamnosus, Enterococcus faecium, Bacillus subtilis) fed to rainbow trout. Likewise other studies present the positive eff ects of various probiotics (Lactococcus lactis, L. sakei, Leuconostoc mesenteroides) on head kidney phagocytic activity and serum alternative complement activity, and lower proliferation of the pathogen A. salmonicida in the intestine (Balcázar et al., 2007a; Balcázar et al., 2009) . Balcázar et al. (2009) also have demonstrated that A. salmonicida is located on the intestinal surfaces of fi sh with asymptomatic infections and probiotic administration may provide a viable alternative to antibiotics by interfering with pathogen colonization and modulation of the immune response. Pieters et al. (2008) demonstrated that dietary probiotics A. sobria strain GC2 can protect rainbow trout against skin infections caused by A. bestiarum and the eukaryotic pathogen I. multifi liis. In addition, fermentation products of probiotics, such as shortchain fatty acids eff ectively act as adopted regulators of both innate and adaptive immune mechanisms in human cells (Van Nuenen et al., 2005) . Through the combined administration of multiple favourable probiotic candidates it may be possible to produce greater benefi ts compared to administration of individual probionts. However, the probiotics must not be pathogenic, not only with regard to the host species but also with regard to aquatic animals in general and human consumers. They must also be free of plasmid-encoded antibiotic resistance and be resistant to bile salts and low pH (Merrifi eld et al., 2010) .
In 2003, Ringø et al. wrote that if we are going to defeat our enemies, the pathogens, we have to be at the same place and time as they are. If probiotic bacteria mostly colonize the pyloric caeca, the probionts will have no eff ect if the pathogens mostly colonizes the mid or hindgut regions and translocate in these regions. The intraperitoneal (IP) method of disease challenge overrides one of the possible methods of probiotic protection against pathogens by masking the potential eff ect of probiotic competitive exclusion within the GI tract. Gastric probiotics may reduce or even prevent gastric infections. The IP challenges do not refl ect the eff ect of probiotics on resistance to infection; rather, they demonstrate the eff ect of probiotics on infected fi sh. Therefore, it is recommended that immersion or cohabitation studies are conducted in future challenge experiments in order to truly assess the full potential of candidate probionts (Merrifi eld et al., 2010) . Probiotic administration methods vary greatly and are not always practical for production level of fi sh farming. The specifi c probiont will likely be dependent on the fi sh species, rearing conditions, and desired outcome of supplementation (Merrifi eld et al., 2010) . In salmonid studies, livecultures are most commonly sprayed or top-dressed onto basal diets. But lyophilised cells, dead cells, disrupted cells, cell-free supernatants and spores have all showed some degree of success (Merrifi eld et al., 2010) . Most commonly used probiotics have been administered via the feed; however, some information regarding administration of probiotics to salmonids via rearing water is available (Irianto and Austin, 2002b; Austin et al., 1995) . These methods may be more applicable in re-circulation facilities or for bathing treatments applied regularly or during times of disease.
Dose dependent studies are currently limited and somewhat contradictory. Appropriate levels are likely to vary depending on the probiont species, host fi sh species, host physiological status, rearing conditions and the specifi c goal of the feeding application (Merrifi eld et al., 2010) . Supplementation has proved to provide shortterm benefi ts but generally probionts have not been detected within the GI tract for periods beyond one to three weeks a er reverting to nonsupplemented diets (Robertson et al., 2000; Balcázar et al., 2007b; Panigrahi et al., 2005; Kim and Austin, 2006a) and presumably probiotic benefi ts are lost a er the probiont is removed from the host. Therefore, there appear to be 3 distinct options for administrative strategy: 1) short-term administration limited to times of need, which is eff ective for gastric colonization, stimulating the immune system, and providing protection against disease when fed prior to pathogenic infection (Irianto and Austin, 2002b) ; 2) constant feed supplementation incorporated into the diet, however, we must consider the possibility that it may not be appropriate to use constant probiotic supplementation for extended periods, similarly as with long-term use of immunostimulants (Sakai, 1999; Bricknell and Dalmo, 2005) ; or 3) cyclic feeding of supplemented diets for short periods which may provide direct benefi ts of short-term administration during the supplemental feeding phase, and during the unsupplemented stage where gastric probiotic populations persist for a number of weeks (Balcázar et al., 2007a; Kim and Austin, 2006a) it may provide certain protection against transient pathogens and continue to induce some degree of immunostimulation (Nikoskelainen et al., 2003; Balcázar et al., 2007a) . Currently, there are no data supporting this hypothesis.
On the basis of the OFIMER program with BioMar and several research institutions, BioMar developed an innovative dietary probiotic concept which resulted in the introduction of the fi rst approved industrial trout and salmon feed containing probiotics in 2010 (DETZ, 2010) .
PREBIOTICS
A prebiotic is defi ned as a non-digestible food ingredient that benefi cially aff ects the host by selectively stimulating the growth and/or the activity of specifi c health promoting bacteria that can improve the host's health (Gibson and Roberfroid, 1995) . According to Gibson et al. (2004) , only three oligosaccharides were classifi ed as prebiotics: inulin, transgalactooligosaccharide (TOS), and lactulose. A more recent study includes fructooligosaccharides (FOS) in the list of prebiotics (Roberfroid, 2007) . Prebiotics have demonstrated some benefi ts in fi sh (Ringø et al., 2010b) but the use of prebiotics in salmonid studies remains relatively limited. For instance, mannanoligisaccharide supplementation induced signifi cant improvements of immunity indicators compared to control groups (Staykov et al., 2007) . Mannanoligisaccharides (MOS) are glucomannoprotein-complexes derived from the cell wall of yeast (S. cerevisiae) (Sohn et al., 2000) . The commercial product GroBiotic®-A is a mixture of partially autolyzed brewer's yeast, dairy ingredient components, and dried fermentation products (Li and Gatlin, 2005) . Sealey et al. (2007) described the eff ect of dietary partially autolysed yeast and GroBiotic®-A on rainbow trout. Fingerlings were fed experimental diets containing 2% prebiotic for 9 weeks. The results showed that the growth performance, immune response, and TNF- mRNA expression level remained unaff ected throughout the experimental period. On the contrary, the whole body energy content and survival from infectious haematopoietic necrosis virus (IHNV) challenge was signifi cantly increased in fi sh fed either partially autolysed yeast or GroBiotic®-A.
SYMBIOTICS
A symbiotic, the combined administration of probiotics and prebiotics, is based on the principle of providing a probiont with a competitive advantage (a fermentable energy source) over competing endogenous populations, thus eff ectively improving the survival and implantation of the live microbial dietary supplement in the gastrointestinal tract of the host (Gibson and Roberfroid, 1995) . One symbiotic study has been conducted in salmonids (Rodriguez-Estrada et al., 2009) . In this study the individual application of the dietary E. faecalis and MOS provided a wide range of benefi ts with regards to immune response and survival in a challenge study with Vibrio anguillarum.
CONCLUSION
Each intensive system has its own specifi cs including health problems. Based on a regular monitoring of the health status of the fi sh stock, the main problems in a given breeding can be estimated. By maintaining good water quality, reducing environmental stressors, providing adequate nutrition and immunization, and with the use of selected substances improving the health status of fi sh, such as immunostimulants, probiotics, prebiotics, symbiotics and so on, losses can be reduced to a minimum.
